Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF, a New Plateau -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (1027)	3/22/2002 8:14:09 PM
From: keokalani'nui	Read Replies (1) \| Respond to of 2243

ASCO, cont. Two possibilities for presentations, not really very exciting are: medx 010 and hgsi's mirostipen. Cell Genesys may have some interesting data, but I did not yet listen to the presentation to find out what. (Had neat vaccine stuff last year, right?) Mr. Pfeffer is expected to provide an update on plans for presentations describing certain of the company's clinical programs at the May 2002 meeting of the American Society of Clinical Oncology (ASCO). biz.yahoo.com Sorry for the pathetic contribution here. Go ducks.